Pakistan meets 80% of its domestic demand of medicines from
local production and 20% through imports. The market for
pharmaceuticals in Pakistan has been expanding at around 7-8% annually over the last few years. Pakistan is also exporting its surplus drugs to a large number of countries particularly to the Asian and African regions with an expanding trade in the newly emerged central Asian states, with almost no local manufacture of medicines, offers an attractive market for industries located in Pakistan.Pakistan has a very vibrant and forward looking Pharma Industry. At the time of independence in 1947, there was hardly any pharma industry in the country. Today Pakistan has about 400 pharmaceutical manufacturing units including those operated by 25 multinationals present in the country. Pharmaceutical Industry is one of the major manufacturing industries in Pakistan providing employment to thousands of people directly and indirectly The National pharma industry has shown a progressive growth over the years, particularly over the last one decade. Currently the industry has the capacity to manufacture a variety of product ranging from simple pills to sophisticated Biotech, Oncology and Value Added Generic compounds. The share of pharmaceutical sector in total exports of Pakistan is approximately 0.6% in 2011 which is a decrease from 0.63% in 2010. The share of the Pakistani pharmaceutical sector in the total exports of 6pharmaceutical products across the world is 0.03% approximately in 2011. The pharmaceutical industry is considered the backbone of public health services in Pakistan. This is strategically important both for the well being of the population in general and for the provision of good yet affordable healthcare in particular. The low cost of production and the huge potential of this sector has attracted major multinationals to establish their operations and production facilities in Pakistan. Local (Pakistani) pharmaceutical companies started in the 1960s but their growth increased in the 1980s.
During the last decade, they made substantial investments in
production facilities and introduced the latest technology along with many new high quality products that were previously either unavailable or available on a limited scale at very expensive prices. By providing quality medicines at economical rates in this fashion, Pakistani pharmaceutical companies have contributed substantially towards public health. IMPORTS AND EXPORTS Pakistan exports its surplus production to a number of countries. This includes Asian countries and Afghanistan with a few of central Asian countries being targeted now. As of 2012 data of PBS, the total export value of Pakistani-manufactured medicines around the world was at $400 million and these exports have been increasing by an annual rate of 7% for the past five years. Pakistan imports 95% of the basis raw materials from China, North America, Europe, India and others. Of the exports of finished drugs, 20% are imported from Switzerland.